| Structure |
Chemical Name |
CAS |
MF |
 |
Benzenebutanoicacid,b-aMino-2,4,5-trifluoro-,Methylester,(bR)- |
881995-69-3 |
C11H12F3NO2 |
 |
Bisoprolol IMpurity |
2226263-67-6 |
C18H31NO4 |
 |
Decitabine iMpurity 5 |
|
|
 |
N-(3-ブロモフェニル)-6,7-ビス(2-メトキシエトキシ)-4-キナゾリンアミン |
328528-74-1 |
C20H22BrN3O4 |
 |
LevetiracetaM IMpurity 3 |
1543353-92-9 |
C8H15NO4 |
![(3R,4R,5R)-4-(1-エチルプロポキシ)-3-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル](/CAS/20150408/GIF/204254-94-4.gif) |
(3R,4R,5R)-4-(1-エチルプロポキシ)-3-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル |
204254-94-4 |
C15H26O7S |
 |
9,11-Anhydrobudesonide |
313474-58-7 |
C25H32O5 |
 |
2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)acetic acid |
113740-61-7 |
C19H21ClN2O2 |
 |
エベロリムス-D4 |
1338452-54-2 |
C53H79D4NO14 |
 |
(2R,3R,4R,5R)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-chloro-4-Methyltetrahydrofuran-3-yl benzoate |
1496551-70-2 |
C31H26ClN3O7 |
 |
1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
114262-49-6 |
C10H14N2O6 |
 |
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide |
835621-11-9 |
C21H15ClF4N4O4 |
 |
Sch-51048 |
161532-65-6 |
C37H42F2N8O3 |
![1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-one](/CAS/20150408/GIF/186521-85-7.gif) |
1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-one |
186521-85-7 |
C15H19ClO |
 |
NSC 351869 |
31350-27-3 |
C14H14N2O4 |
 |
N-(1-エチルピロリジン-2-イルメチル)-4-アミノ-5-ヨード-2-メトキシベンズアミド |
176849-91-5 |
C15H22IN3O2 |
![N,N'-Vis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethyl-1,3-propanediamine dihydrochloride](/CAS/20180808/GIF/63434-11-7.gif) |
N,N'-Vis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethyl-1,3-propanediamine dihydrochloride |
63434-11-7 |
C25H39ClN2O4 |
![(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol](/CAS/20180808/GIF/915095-96-4.gif) |
(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol |
915095-96-4 |
C24H29ClO8 |
 |
Doxorubicin Imp B HBr salt |
148218-14-8 |
C29H35Br2NO11 |
 |
(R)-2-(Boc-aMino)-2-phenylethyl 4-Methylbenzenesulfonate |
126610-77-3 |
C20H25NO5S |
 |
(2R,3R,4R,5S)-5-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-2-(2-hydroxyethyl)tetrahydrofuran-2,3,4-triol |
|
C23H27ClO7 |
![Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:)](/CAS/20211123/GIF/571189-66-7.gif) |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:) |
571189-66-7 |
C22H28ClN7O |
 |
Olaparib iMpurity |
2905342-00-7 |
C24H25FN4O4 |
 |
(2S,3R,4R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-((S)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol |
|
C21H25ClO6 |
 |
(R)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl) butanoate .(R)-2-hydroxy-2-phenylacetate |
1253055-94-5 |
C19H20F3NO5 |
 |
Olaparib iMpurity A |
|
|
![N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/GIF/1252883-90-1.gif) |
N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1252883-90-1 |
C20H25N5 |
 |
P219490 |
937370-10-0 |
C20H21N5Na2O6** |
 |
(S)-4-(TERT-ブチルトキシ)-2-イソプロピル-4-オキソブタン酸 |
134807-43-5 |
C11H20O4 |
![2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, 1-ethyl 9-(1-Methylethyl) ester, 5-oxide](/CAS/20180808/GIF/1422284-16-9.gif) |
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, 1-ethyl 9-(1-Methylethyl) ester, 5-oxide |
1422284-16-9 |
C18H28N5O10P |
![(R)-α-[2-(1-naphthalenyloxy)ethyl]-benzeneMethanol](/CAS/20180808/GIF/156453-53-1.gif) |
(R)-α-[2-(1-naphthalenyloxy)ethyl]-benzeneMethanol |
156453-53-1 |
C19H18O2 |
![(1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB72664140.gif) |
(1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
2096989-56-7 |
C23H28F2N6O4S |
 |
Fosaprepitant iMpurity |
|
|
 |
bortezoMib iMpurity F |
|
|
 |
cefoxitin iMpurity A |
|
|
 |
4-(2-Aminophenyl)-3-morpholinone |
1082588-73-5 |
C10H12N2O2 |
 |
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine |
1428185-71-0 |
C22H22F3N |
![1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-](/CAS/20180808/GIF/344418-92-4.gif) |
1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- |
344418-92-4 |
C16H20N6O |
 |
Erlotinib impurity A |
183321-85-9 |
C21H20ClN3O3 |
![1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl-](/CAS/20150408/GIF/213699-53-7.gif) |
1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl- |
213699-53-7 |
C15H17NO6 |
 |
Budesonide iMpurity |
192057-49-1 |
C24H32O6 |
 |
dextroMethorphan iMpurity |
|
|
 |
Fluticasone IMpurity |
397864-58-3 |
C27H30F2O6S |
 |
Valdecoxib iMpurity |
|
|
 |
Fluconazole IMpurity-H |
|
|
 |
Retigabine Dihydrochloride Impurity |
1432063-93-8 |
C16H19ClFN3O2 |
 |
Adrenaline IMpurity F |
78995-75-2 |
C9H13NO5S |
 |
AztreonaM IMpurity D |
|
|
 |
メタンスルフィン酸4-メタンスルホニルオキシブタニル |
1797106-48-9 |
C6H14O5S2 |
 |
Deferasirox Ethyl Ester |
201530-79-2 |
C23H19N3O4 |
 |
MetoclopraMide IMpurity F |
38339-95-6 |
C13H20ClN3O2 |
 |
Metronidazole IMpurity E |
|
|
 |
Propofol IMpurity H |
|
|
 |
R-(-)-O-DesMethyl-Venlafaxine-d6 |
1062609-96-4 |
C16H25NO2 |
 |
Palbociclib Impurity 38 |
|
|
 |
Pemetrexed Impurity 38 |
|
|
 |
Posaconazole Impurity 74 |
|
|
 |
Rabeprazole Impurity 21 |
|
|
 |
Sitagliptin Impurity 52 |
|
|
 |
Tafluprost Impurity 5 |
|
|
 |
Ticagrelor Impurity 112 |
|
|
 |
Ticagrelor Impurity 96 |
1643413-84-6 |
C9H9F2N |
 |
Tofacitinib Impurity 116 |
|
|
 |
Tofacitinib Impurity 121 |
|
|
 |
Trelagliptin Impurity 28 |
|
|
 |
Vildagliptin Impurity 31 |
119694-48-3 |
C10H14N4O6 |
 |
Beclometasone Impurity M |
|
|
 |
デスメチルカルベジロール |
72956-44-6 |
C23H24N2O4 |
 |
Tolvaptan Impurity 7 |
1432725-23-9 |
C26H26N2O3 |
 |
Dexchlorpheniramine impurity E |
|
|
 |
Diquafosol Impurity F |
|
|
 |
Dasatinib iMpurity F |
|
|
 |
Ribavirin IMp. C (EP) |
|
|
 |
SalMeterol IMpurity B |
|
C25H37NO4 |
 |
Sitagliptin N-Phoshate IMpurity |
1351498-25-3 |
C16H16F6N5O4P |
 |
SulbactaM IMpurity E |
|
|
 |
TriMethopriM IMpurity A |
213745-86-9 |
C15H20N4O3 |
 |
Varenicline Metadinitro IMpurity |
|
|
 |
1-(4-メトキシフェニル)-2-メチルプロパン-2-アミン |
56490-94-9 |
C11H17NO |
![2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine](/CAS/20150408/GIF/877858-27-0.gif) |
2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine |
877858-27-0 |
C12H12N2O |
 |
1,3,5-Tri-O-benzoyl-2-deoxy-2-fluoro-α-D-ribofuranose |
704916-12-1 |
C26H21FO7 |
 |
rac-(3R*)-3-(4-クロロフェニル)-N,N-ジメチル-3-(2-ピリジニル)プロパン-1-アミン |
78539-96-5 |
C16H19ClN2 |
 |
9-(2,5-d|Dioxo-L-3-aMino-1-pyrrolidineacetic acid)-10-deglycine DaptoMycin |
121869-35-0 |
C72H99N17O25 |
![(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine](/CAS/20150408/GIF/38284-47-8.gif) |
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine |
38284-47-8 |
C17H31NO2 |
メタノン](/CAS/GIF/105356-89-6.gif) |
[4-(4-アミノ-6-ヒドロキシ-7-メトキシ-2-キナゾリニル)-1-ピペラジニル](テトラヒドロ-2-フラニル)メタノン |
105356-89-6 |
C18H23N5O4 |
![2,2'-[4-(2-Methylpropoxy)-1,3-phenylene]bis[4-Methyl-5-thiazolecarboxylic Acid 5,5'-DiMethyl Ester](/CAS/20180808/GIF/1330632-47-7.gif) |
2,2'-[4-(2-Methylpropoxy)-1,3-phenylene]bis[4-Methyl-5-thiazolecarboxylic Acid 5,5'-DiMethyl Ester |
1330632-47-7 |
C22H24N2O5S2 |
 |
2-(DiethylaMino)-N-(2,4-diMethylphenyl)acetaMide Hydrochloride |
17289-54-2 |
C14H23ClN2O |
 |
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine |
641571-16-6 |
C11H10F3N3 |
![4-[[3-(4-Methylphenyl)-3-oxo-1-(trifluoroMethyl)propylidene]aMino]benzenesulfonaMide](/CAS/20150408/GIF/1061214-09-2.gif) |
4-[[3-(4-Methylphenyl)-3-oxo-1-(trifluoroMethyl)propylidene]aMino]benzenesulfonaMide |
1061214-09-2 |
C17H15F3N2O3S |
 |
5-(Ethoxycarbonyl)-2-(hydroxyMethyl-6-Methyl-4-(3-nitrophenyl)nicotinic Acid |
89267-43-6 |
C17H16N2O7 |
 |
9-L-β-Aspartic acid-daptoMycin |
123180-72-3 |
C72H101N17O26 |
 |
Chlorhexidine Digluconate IMpurity K |
1381962-77-1 |
C22H29Cl2N9O |
 |
シクロプロピル3-フルオロベンジルケトン |
952722-64-4 |
C11H11FO |
 |
Linear DaptoMycin |
883991-21-7 |
C72H103N17O27 |
 |
N,N-DiMethylaMidino) Urea |
98026-16-5 |
C4H10N4O |
 |
RAC デヒドロ-O-デスメチルベンラファキシン |
1346600-38-1 |
C16H23NO |
 |
3-ヒドロキシデスロラタジン |
119410-08-1 |
C19H19ClN2O |
 |
Vinorelbine N'b-Oxide Sulfate Salt |
74075-34-6 |
C45H54N4O9 |
 |
Linagliptin iMpurity G |
668270-11-9 |
C25H28N8O2 |
 |
Tadalafil EP IMpurity F |
|
|